Archive for June, 2007
Patient Choice And Treatment Alternatives For Arthritis
Patients with osteoarthritis (OA) and rheumatoid arthritis (RA) face different treatment options and determining which ones to try can be confusing. Two new studies published in the July 2007 issue of Arthritis & Rheumatism (http://www.interscience.wiley. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
Common Hip Condition May Not Always Cause Osteoarthritis In Some Racial Groups
Osteoarthritis is the most common joint disorder worldwide, yet the cause of osteoarthritis of the hip is still unknown. One condition that may play a role is femoro-acetabular impingement (FAI), in which the femoral head of the thighbone causes damage by rubbing abnormally on the hip socket (acetabulum). FAI caused by an abnormality in the hip socket can lead to osteoarthritis, but it is not known whether FAI that is not caused by a defect can additionally lead to the condition. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
Further Legitimization Of Fibromyalgia As A True Medical Condition
Fibromyalgia, a chronic, widespread pain in muscles and soft tissues accompanied by fatigue, is a fairly common condition that does not manifest any structural damage in an organ. Twenty-five years ago, Muhammad B. Yunus, MD, and colleagues published the first controlled study of the clinical characteristics of fibromyalgia syndrome. That seminal scoop, published in Seminars in Arthritis and Rheumatism, led directly to formal recognition of that disease by the medical community. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
European Medicines Agency Recommends Restricted Use For Piroxicam
The European Medicines Agency (EMEA) has recommended restrictions on the use of piroxicam-containing medicinal products considering of the risk of gastrointestinal side effects and serious skin reactions. The Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that piroxicam should no longer be used for treatment of short-term painful and inflammatory conditions. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
AMA Adopts New Policies On Childhood Anaphylaxis, Emergency Contraception, And Human-Veterinary Medicine
The American Medical organization (AMA), the nation’s largest physician group, voted today at its Annual Meeting to adopt the following new policies. TREATMENT OF CHILDHOOD ALLERGIC (ANAPHYLACTIC) REACTIONS: The AMA voted to adopt new policy calling on all states to enact laws permitting students to carry prescribed epinephrine or other medications for asthma or anaphylaxis. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
Allergy-Fighting Buckyballs Developed By Researchers
A research team has identified a new biological operate for a soccer ball-shaped nanoparticle called a buckyball - the ability to block allergic response, setting the stage for the development of new therapies for allergy.Allergic disease is the sixth leading cause of chronic disease in the United States, and while various treatments have been developed to control allergy, no cure has been found. These findings advance the emerging field of medicine known as nanoimmunology. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
Removal Of Black Triangle Status For Crestor, UK
Following a comprehensive analysis of the pre and post marketing details by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM) the risk/benefit profile for rosuvastatin (CRESTOR) has been confirmed and black triangle status has been removed for rosuvastatin. [click link for full article]
Original post by Women’s Health / Gynecology News From Medical News Today
